These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11884226)

  • 1. Phosphoinositide 3-kinase in immunological systems.
    Fruman DA; Cantley LC
    Semin Immunol; 2002 Feb; 14(1):7-18. PubMed ID: 11884226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide 3-kinase: diverse roles in immune cell activation.
    Deane JA; Fruman DA
    Annu Rev Immunol; 2004; 22():563-98. PubMed ID: 15032589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell receptor signaling: picky about PI3Ks.
    Limon JJ; Fruman DA
    Sci Signal; 2010 Aug; 3(134):pe25. PubMed ID: 20699473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer.
    Katso R; Okkenhaug K; Ahmadi K; White S; Timms J; Waterfield MD
    Annu Rev Cell Dev Biol; 2001; 17():615-75. PubMed ID: 11687500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3Ks in lymphocyte signaling and development.
    Okkenhaug K; Fruman DA
    Curr Top Microbiol Immunol; 2010; 346():57-85. PubMed ID: 20563708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the controversial role of PI3K signalling in CD4
    Poli A; Fiume R; Mongiorgi S; Zaurito A; Sheth B; Vidalle MC; Hamid SA; Kimber S; Campagnoli F; Ratti S; Rusciano I; Faenza I; Manzoli L; Divecha N
    Adv Biol Regul; 2020 May; 76():100722. PubMed ID: 32362560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies.
    Foster JG; Blunt MD; Carter E; Ward SG
    Pharmacol Rev; 2012 Oct; 64(4):1027-54. PubMed ID: 23023033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of angiogenesis by PI3K signaling networks.
    Graupera M; Potente M
    Exp Cell Res; 2013 May; 319(9):1348-55. PubMed ID: 23500680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide 3-kinases in T lymphocyte activation.
    Ward SG; Cantrell DA
    Curr Opin Immunol; 2001 Jun; 13(3):332-8. PubMed ID: 11406365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of PI3Ks in leukocyte chemotaxis and phagocytosis.
    Stephens L; Ellson C; Hawkins P
    Curr Opin Cell Biol; 2002 Apr; 14(2):203-13. PubMed ID: 11891120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines.
    Sotsios Y; Ward SG
    Immunol Rev; 2000 Oct; 177():217-35. PubMed ID: 11138779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling.
    Fruman DA
    Curr Opin Immunol; 2004 Jun; 16(3):314-20. PubMed ID: 15134780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITAMs versus ITIMs: striking a balance during cell regulation.
    Billadeau DD; Leibson PJ
    J Clin Invest; 2002 Jan; 109(2):161-8. PubMed ID: 11805126
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocytes on the move with phosphoinositide 3-kinase and its downstream effectors.
    Procko E; McColl SR
    Bioessays; 2005 Feb; 27(2):153-63. PubMed ID: 15666353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function.
    Wan YY; Chi H; Xie M; Schneider MD; Flavell RA
    Nat Immunol; 2006 Aug; 7(8):851-8. PubMed ID: 16799562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key molecules involved in receptor-mediated lymphocyte activation.
    O'Shea JJ; Johnston JA; Kehrl J; Koretzky G; Samelson LE
    Curr Protoc Immunol; 2001 Nov; Chapter 11():Unit 11.9A. PubMed ID: 18432708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K in lymphocyte development, differentiation and activation.
    Okkenhaug K; Vanhaesebroeck B
    Nat Rev Immunol; 2003 Apr; 3(4):317-30. PubMed ID: 12669022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell activation and the cytoskeleton.
    Acuto O; Cantrell D
    Annu Rev Immunol; 2000; 18():165-84. PubMed ID: 10837056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction.
    Suzuki H; Matsuda S; Terauchi Y; Fujiwara M; Ohteki T; Asano T; Behrens TW; Kouro T; Takatsu K; Kadowaki T; Koyasu S
    Nat Immunol; 2003 Mar; 4(3):280-6. PubMed ID: 12563258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of PI3K assays for novel drug discovery.
    Yanamandra M; Mitra S; Giri A
    Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.